Martin Tolar

Martin Tolar

Company: Alzheon

Job title: Founder, President & CEO

Seminars:

Live Q&A With Your Expert Speakers 4:20 pm

Read more

day: Day One

ALZ-801 Phase 3 Program: A Targeted Oral Disease Modifying Therapy for Alzheimer’s Disease 3:10 pm

Read more

day: Day One

Kick-off Panel Discussion 9:10 am

Overview of recent encouraging clinical case studies across the industry – what are the treatments that are around the corner promising results? What has Biogen’s aducanumab story taught us? What new research has been revealed to shine light on the mechanisms that are driving neurodegenerative pathology? Is there space for all of these different modalities…Read more

day: Day One

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.